ASCIMIB 40 MG (Asciminib)

ASCIMIB 40 MG (Asciminib) is an advanced targeted therapy for patients with Chronic Myeloid Leukemia (CML), especially those who need alternative treatment after previous therapies. It works through a unique mechanism of action, offering improved precision and a modern approach to leukemia management. This medication is considered effective for resistant CML cases, requires regular medical monitoring, and is conveniently taken as an oral tablet. WordsCharactersReading time WordsCharactersReading time WordsCharactersReading time WordsCharactersReading time